Similar articles for PMID: 31122236

Year	Number of Results
1949	1
1998	1
2001	1
2003	1
2004	2
2005	2
2006	4
2007	1
2008	2
2009	1
2010	3
2011	6
2012	6
2013	8
2014	11
2015	12
2016	13
2017	14
2018	16
2019	24
2020	15
2021	11
2022	10
2023	8
2024	2

1

Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.

Yuan NN, Cai CZ, Wu MY, Su HX, Li M, Lu JH. Yuan NN, et al. BMC Complement Altern Med. 2019 May 23;19(1):109. doi: 10.1186/s12906-019-2510-z. BMC Complement Altern Med. 2019. PMID: 31122236 Free PMC article.

2

Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.

Singh AK, Singh SK, Nandi MK, Mishra G, Maurya A, Rai A, Rai GK, Awasthi R, Sharma B, Kulkarni GT. Singh AK, et al. Cent Nerv Syst Agents Med Chem. 2019;19(3):154-170. doi: 10.2174/1871524919666190820160053. Cent Nerv Syst Agents Med Chem. 2019. PMID: 31429696 Review.

3

Berberine: a potential multipotent natural product to combat Alzheimer's disease.

Ji HF, Shen L. Ji HF, et al. Molecules. 2011 Aug 9;16(8):6732-40. doi: 10.3390/molecules16086732. Molecules. 2011. PMID: 21829148 Free PMC article. Review.

4

Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.

Huang M, Jiang X, Liang Y, Liu Q, Chen S, Guo Y. Huang M, et al. Exp Gerontol. 2017 May;91:25-33. doi: 10.1016/j.exger.2017.02.004. Epub 2017 Feb 20. Exp Gerontol. 2017. PMID: 28223223

5

Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.

Singh A, Dhaneshwar S, Mazumder A. Singh A, et al. Curr Rev Clin Exp Pharmacol. 2023;18(2):182-190. doi: 10.2174/2772432816666210910104306. Curr Rev Clin Exp Pharmacol. 2023. PMID: 34515019

6

Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research.

Ye M, Fu S, Pi R, He F. Ye M, et al. J Pharm Pharmacol. 2009 Jul;61(7):831-7. doi: 10.1211/jpp/61.07.0001. J Pharm Pharmacol. 2009. PMID: 19589224 Review.

7

Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.

Akbar M, Shabbir A, Rehman K, Akash MSH, Shah MA. Akbar M, et al. J Food Biochem. 2021 Oct;45(10):e13936. doi: 10.1111/jfbc.13936. Epub 2021 Sep 14. J Food Biochem. 2021. PMID: 34523148 Review.

8

Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.

Hussien HM, Abd-Elmegied A, Ghareeb DA, Hafez HS, Ahmed HEA, El-Moneam NA. Hussien HM, et al. Food Chem Toxicol. 2018 Jan;111:432-444. doi: 10.1016/j.fct.2017.11.025. Epub 2017 Nov 21. Food Chem Toxicol. 2018. PMID: 29170048

9

Neuroprotective effects of berberine on recognition memory impairment, oxidative stress, and damage to the purinergic system in rats submitted to intracerebroventricular injection of streptozotocin.

de Oliveira JS, Abdalla FH, Dornelles GL, Palma TV, Signor C, da Silva Bernardi J, Baldissarelli J, Lenz LS, de Oliveira VA, Chitolina Schetinger MR, Melchiors Morsch VM, Rubin MA, de Andrade CM. de Oliveira JS, et al. Psychopharmacology (Berl). 2019 Feb;236(2):641-655. doi: 10.1007/s00213-018-5090-6. Epub 2018 Oct 30. Psychopharmacology (Berl). 2019. PMID: 30377748

10

The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.

Zhang S, Zhu Q, Chen JY, OuYang D, Lu JH. Zhang S, et al. Phytomedicine. 2020 Dec;79:153316. doi: 10.1016/j.phymed.2020.153316. Epub 2020 Aug 31. Phytomedicine. 2020. PMID: 32942205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year